For example, Qi et al., identified PLEKHF1 as a potential biomarker for diabetic atherosclerosis26; also, PLEKHF1 was shown to be a potential biomarker for chronic graft-versus-host disease, the accuracy of which was confirmed by several clinical independent validation studies27. Here, PLEKHF1 is linked to chronic graft versus host disease.